Bioinnovation Institute reaches DKK 1bn milestone
In just four years, Bioinnovation Institue (BII) has reached a significant milestone, as the life science incubator's former start-ups have surpassed DKK 1bn (USD 153.8m) in external financing.
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen and catherine brett
The streets of Denmark have been paved with gold for biotech companies over the past few years, and a number of firms have gained historically large amounts from investors.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Set-in-stone criteria will reduce risk for new biotech fund
For subscribers
